Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole.
The in vitro activity of cefuroxime, a new cephalosporin derivative, was compared with that of cephaloridine, cephalothin, and cefamandole against strains of gram-positive and gram-negative bacteria recently isolated from clinical sources. Cefuroxime showed very similar activity to cefamandole against Staphylococcus aureus, Haemophilus influenzae, and most members of the Enterobacteriaceae. It was more active than cefamandole against gonococci, pneumococci, and most streptococci. Increasing the inoculum size appeared to have less effect on the minimum inhibitory concentrations of cefuroxime for gram-negative bacilli than has been found with the other cephalosporin derivatives, and minimum bactericidal concentrations of cefuroxime were only marginally greater than minimum inhibitory concentrations.
D001419:Bacteria / Q000187:drug effects*; D002509:Cephaloridine / Q000494:pharmacology*; D002511:Cephalosporins / Q000009:adverse effects* / Q000494:pharmacology*; D002512:Cephalothin / Q000494:pharmacology*; D003470:Culture Media; D005663:Furans / Q000494:pharmacology; D008333:Mandelic Acids / Q000009:adverse effects; D008826:Microbial Sensitivity Tests
D002511:Cephalosporins; D003470:Culture Media; D005663:Furans; D008333:Mandelic Acids; D002509:Cephaloridine; D002512:Cephalothin